{"id":177745,"date":"2026-01-26T21:45:38","date_gmt":"2026-01-27T02:45:38","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=177745"},"modified":"2026-01-26T21:45:38","modified_gmt":"2026-01-27T02:45:38","slug":"innova-captab-limited-reports-robust-q3-fy26-results-revenue-surges-42-amid-global-expansion","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/innova-captab-limited-reports-robust-q3-fy26-results-revenue-surges-42-amid-global-expansion\/","title":{"rendered":"Innova Captab Limited Reports Robust Q3 FY26 Results. Revenue Surges 42% Amid Global Expansion"},"content":{"rendered":"\n<p>Innova Captab Limited (NSE: INNOVACAP | BSE: 544067) announced its unaudited financial results for the third quarter and nine months ended December 31, 2025, on January 23, 2026. The company, a leading integrated pharmaceutical player, demonstrated a significant acceleration in revenue growth driven by its dual focus on Contract Development and Manufacturing Organization (CDMO) services and Branded Generics.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Market Capitalization<\/strong><\/h2>\n\n\n\n<p>As of January 23, 2026, the company&#8217;s stock performance and valuation are summarized as follows:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Current Stock Price: \u20b9678.05 (NSE).<\/li>\n\n\n\n<li>Market Capitalization: Approximately \u20b93,880.14 Crores.<\/li>\n\n\n\n<li>Exchange: Listed on both National Stock Exchange (NSE) and BSE Limited.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Latest Quarterly Performance (Q3 FY26)<\/strong><\/h2>\n\n\n\n<p>The company reported a stellar top-line performance for the quarter ended December 31, 2025:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Revenue from Operations: \u20b9450.3 Crore, a year-on-year (YoY) increase of 42.3% from \u20b9316.5 Crore in Q3 FY25.<\/li>\n\n\n\n<li>EBITDA: \u20b971.1 Crore, up 39.6% YoY.<\/li>\n\n\n\n<li>Net Profit (PAT): \u20b942.15 Crore, representing a 23.25% YoY increase and a sharp 42.06% sequential (QoQ) recovery.<\/li>\n\n\n\n<li>Interim Dividend: The Board declared an interim dividend of \u20b92 per equity share (20% of face value).<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/Innova_Captab_Q3FY26_vs_Q3FY25_Landscape-1024x512.png\" alt=\"\" class=\"wp-image-177747\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/Innova_Captab_Q3FY26_vs_Q3FY25_Landscape-1024x512.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/Innova_Captab_Q3FY26_vs_Q3FY25_Landscape-300x150.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/Innova_Captab_Q3FY26_vs_Q3FY25_Landscape-768x384.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/Innova_Captab_Q3FY26_vs_Q3FY25_Landscape-1536x768.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/Innova_Captab_Q3FY26_vs_Q3FY25_Landscape-2048x1024.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Segment Updates<\/strong><\/h2>\n\n\n\n<p>Innova Captab&#8217;s growth was broad-based across its core segments:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CDMO Segment: Recorded 29% YoY growth in Q3 FY26, fueled by deeper engagement with its over 300 clients and a portfolio exceeding 3,700 products.<\/li>\n\n\n\n<li>Branded Generics: This vertical saw a sharp 79% YoY growth in Q3 FY26, supported by a network of 220,000+ touchpoints in India and exports to over 60 countries.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Regulatory Milestones<\/strong><\/h2>\n\n\n\n<p>The company recently received GMP Compliance from UK-MHRA for its Cephalosporin unit in Baddi and from PIC\/s for its Jammu facility, enhancing its access to regulated international markets.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Equity Analyst Commentary<\/strong><\/h2>\n\n\n\n<p>Analysts have noted a &#8220;cautious stance&#8221; despite the strong revenue surge. While the company is delivering record quarterly revenues, concerns persist regarding:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Margin Compression: PAT margins (9.36%) have contracted from Q3 FY24 levels (10.81%) due to rising employee costs, which surged 55% YoY.<\/li>\n\n\n\n<li>Valuation: With a PEG ratio of 6.02x and a P\/E ratio around 31x, some analysts consider the stock &#8220;expensive&#8221; relative to its historical growth and industry benchmarks.<\/li>\n\n\n\n<li>Technical Momentum: The stock has faced a downward trend over the past year, trading below key moving averages, leading some analysts to recommend waiting for a better entry point near the 52-week low of \u20b9625.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Guidance and Future Outlook<\/strong><\/h2>\n\n\n\n<p>Management remains optimistic, targeting a consistent 20%+ growth trajectory. The company aims to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Triple Targets: Double its top line, EBITDA, and PAT over the next three years.<\/li>\n\n\n\n<li>Capacity Expansion: Plans to invest \u20b9300 Crore in capital expenditure for capacity addition and R&amp;D to drive a 25% revenue increase through regulated market entry.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Strategic Focus <\/h2>\n\n\n\n<p>Future growth will be anchored by the commercialization of the Jammu plant and vertical integration into Active Pharmaceutical Ingredients (API).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Innova Captab Limited (NSE: INNOVACAP | BSE: 544067) announced its unaudited financial results for the third quarter and nine months ended December 31, 2025, on January 23, 2026. The company, a leading integrated pharmaceutical player, demonstrated a significant acceleration in revenue growth driven by its dual focus on Contract Development and Manufacturing Organization (CDMO) services [&hellip;]<\/p>\n","protected":false},"author":2378,"featured_media":125269,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5,1941,1],"tags":[10169,1115],"class_list":["post-177745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest","category-stock-analysis","category-finance-stocks","tag-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":177750,"url":"https:\/\/alphastreet.com\/india\/innova-captab-limited-accelerating-strategic-growth-with-strong-q3-and-9-month-fy26-performance\/","url_meta":{"origin":177745,"position":0},"title":"Innova Captab Limited Accelerating Strategic Growth with Strong Q3 and 9-Month FY26 Performance","author":"Staff Correspondent","date":"January 26, 2026","format":false,"excerpt":"Innova Captab Limited (NSE: INNOVACAP\/BSE: 544067), is a leading integrated pharmaceutical company with a comprehensive business model spanning the entire value chain, including research and development, manufacturing, and marketing. The company serves as a preferred CDMO partner for prominent global pharmaceutical companies while maintaining a robust branded generics business in\u2026","rel":"","context":"In &quot;LATEST&quot;","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":177762,"url":"https:\/\/alphastreet.com\/india\/innova-captab-limited-performance-market-environment-and-competitive-position\/","url_meta":{"origin":177745,"position":1},"title":"Innova Captab Limited Performance, Market Environment, and Competitive Position","author":"Staff Correspondent","date":"January 26, 2026","format":false,"excerpt":"Innova Captab Limited (NSE: INNOVACAP) has emerged as a noteworthy player in India's pharmaceutical landscape, combining contract development and manufacturing (CDMO) services with a branded generics business. In recent quarters, the company has delivered strong top-line growth coupled with improving profitability, reflecting both operational execution and expanding market reach. In\u2026","rel":"","context":"In &quot;LATEST&quot;","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":178128,"url":"https:\/\/alphastreet.com\/india\/innova-captab-q3-fy26-earnings-results\/","url_meta":{"origin":177745,"position":2},"title":"Innova Captab Q3 FY26 Earnings Results","author":"Divyansh_Kasana","date":"January 28, 2026","format":false,"excerpt":"Executive Summary Innova Captab Ltd reported Q3FY26 revenues of \u20b9450 crore, up 42.41% YoY, with consolidated net profit rising 23.53% to \u20b942 crore. Total expenses increased 44.0% YoY to \u20b9396 crore, reflecting strong revenue momentum despite cost pressures. Revenue & Growth Revenues jumped to \u20b9450.00 crore in Q3FY26 from \u20b9316.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/INNO.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/INNO.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/INNO.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/INNO.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/INNO.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/INNO.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142040,"url":"https:\/\/alphastreet.com\/india\/bse-ltd-nse-bse-q3fy23-results-out-total-income-rise-12-yoy\/","url_meta":{"origin":177745,"position":3},"title":"BSE Ltd. (NSE: BSE): Q3FY23 Results Out; Total Income rise 12% YoY","author":"Divyansh_Kasana","date":"February 16, 2023","format":false,"excerpt":"BSE Ltd. (NSE: BSE) is the first and one of the largest stock exchanges in India, located in Mumbai. BSE offers trading in equities, derivatives, currencies, and debt securities, and has a wide range of listed companies from various sectors. In addition, BSE provides a number of other services related\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":178994,"url":"https:\/\/alphastreet.com\/india\/ashoka-buildcon-shares-rise-stock-closes-higher-on-nse-and-bse\/","url_meta":{"origin":177745,"position":4},"title":"Ashoka Buildcon Shares Rise; Stock Closes Higher on NSE and BSE","author":"Staff Correspondent","date":"February 2, 2026","format":false,"excerpt":"Shares of Ashoka Buildcon Limited (NSE: ASHOKA; BSE: 533271) closed at \u20b9148.80 on Friday, up 3.01% from the previous session\u2019s finish, according to live exchange data. The stock traded between \u20b9139.95 and \u20b9268.00 over the past 52 weeks, reflecting active movement on the bourses. Market Capitalization As of the latest\u2026","rel":"","context":"In &quot;LATEST&quot;","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":177084,"url":"https:\/\/alphastreet.com\/india\/epack-durable-ltd-shares-slip-after-q3-fy26-earnings-release\/","url_meta":{"origin":177745,"position":5},"title":"Epack Durable Ltd Shares Slip After Q3 FY26 Earnings Release","author":"Staff Correspondent","date":"January 21, 2026","format":false,"excerpt":"Epack Durable Ltd (NSE: EPACK, BSE: 544095) shares closed at around \u20b9260.8 on Wednesday, down approximately 2.4% from the prior session\u2019s close, following the company\u2019s announcement of its third quarter fiscal 2026 results. Market Capitalization At the close of trading, the company\u2019s market capitalization stood at approximately \u20b92,500 crore. Latest\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/177745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2378"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=177745"}],"version-history":[{"count":3,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/177745\/revisions"}],"predecessor-version":[{"id":177749,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/177745\/revisions\/177749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125269"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=177745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=177745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=177745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}